{
  "docId": "019de074-f95f-763f-9a80-be3b653e0df1",
  "docSlug": "502ed4e7545b260f09647399e486ae2c",
  "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 28 slides",
  "authorId": "matinas-biopharma",
  "authorName": "Matinas BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 28,
  "prevPage": 27,
  "nextPage": null,
  "slideType": "thesis_headline",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide combines financial runway, a timeline of upcoming catalysts, and a summary of the investment thesis (floor vs upside).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-f95f-763f-9a80-be3b653e0df1/28",
  "deckHref": "/decks/019de074-f95f-763f-9a80-be3b653e0df1",
  "deckJsonHref": "/decks/019de074-f95f-763f-9a80-be3b653e0df1.json",
  "deckAnchorHref": "/decks/019de074-f95f-763f-9a80-be3b653e0df1#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.55,
        "x": 0.38,
        "y": 0.6
      },
      "kind": "framework",
      "text": "Solid Value FLOOR (MAT2203) vs Substantial UPSIDE (LNCs/PS-NPs)",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1675a425-7d2e-48df-8553-f2be1b9ed4c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "Runway into 2H 2024; $24.9M in Cash; Non-Dilutive Financing Options",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be982eb5-d8a8-4827-8d84-117dc339d558",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.5,
        "x": 0.38,
        "y": 0.05
      },
      "kind": "list",
      "text": "2023 Milestones & Catalysts: Q2 FDA Meeting, Q3 In vitro data, 2H Partnerships/Grants, Q4 In vivo data",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e09da1b-e6f7-4cc3-a97b-810207e70214",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Matinas Investment Thesis",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c2c3ad34-faed-499c-afa4-bb21bb7e5a27",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Thesis archetype",
      "slug": "thesis-archetype",
      "agent": null,
      "layer": "slide",
      "matchId": "67eefb79-88ef-447a-b71b-dc5814a31c3a",
      "evidence": "Solid Value FLOOR (MAT2203) vs Substantial UPSIDE (LNCs/PS-NPs)",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "5d56bd0b-9bfd-4832-a722-2bad87940bac",
      "evidence": "Contrasting the 'Solid Value FLOOR' with 'Substantial UPSIDE' to frame the investment opportunity.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}